Aigen Investment Management, LP Lantheus Holdings, Inc. Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$48.76 - $77.67 $364,285 - $580,272	7,471 New	7,471 $380,000
Q2 2022 Aug 02, 2022	SELL	$55.54 - $72.65 $773,949 - $1.01 Million	-13,935 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$24.28 - $56.64 $338,341 - $789,278	13,935 New	13,935 $771,000
Q4 2020 Feb 12, 2021	SELL	$10.75 - $14.91 $398,233 - $552,340	-37,045 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$11.98 - $16.34 $246,344 - $335,999	-20,563 Reduced 35.69%	37,045 $469,000
Q2 2020 Aug 10, 2020	BUY	$10.34 - $15.51 $385,992 - $578,988	37,330 Added 184.09%	57,608 $824,000
Q1 2020 May 08, 2020	BUY	$9.11 - $20.05 $154,933 - $340,990	17,007 Added 519.93%	20,278 $259,000
Q4 2019 Feb 04, 2020	BUY	$18.47 - $24.03 $60,415 - $78,602	3,271 New	3,271 $67,000

541

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.08B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.